In an interview with DNA Weekly (link: https://www.dnaweekly.com/blog/genz-interview/), CEO Umut Ağyüz discusses the advancements and future impact of Genz Biotechnology. Genz is a biotech company focused on developing innovative and accessible diagnostic solutions. Their primary areas of focus include early cancer diagnosis and addressing new pandemics. The company has developed the GENZPRO lab-accurate point-of-care testing system and aims to lead the market in POC diagnostics. Genz believes in the importance of personalized medicine and anticipates the rise of technologies supporting point-of-care patient tracking. They envision a future with larger capacity diagnostic devices for mass testing and smaller, portable devices for home or clinic use. Genz is committed to contributing to the development of testing reagent technologies.
